Buy?, page-70

UNILIFE is an innovative company that has already developed a range of products that are critical to big pharmaceutical companies.
Amgen or not future deals and transactions will make UNILIFE an unbelievable buy at these prices even in the short term.
The value of this company is difficult to calculate as it's such an enormous market an extra percent on conservative future market share is 100's of millions, and UNILIFE is a leader in an industry that you can't copy innovation, due to regulations and trials required.
In summary value was there before Amgen announcement, the development took liger and cost more, it's done but the time taken and missed dates allowed shorts to manipulate to date.
Those days are OVER.
SHORTS WILL BE BURNED.
SP now ready to rocket.
You need to watch UNIS as it leads.
The NAS will deliver the $$$$'s